Blood screening | Tumor marker | Respiratory | Antibody titer for PET | ||||
---|---|---|---|---|---|---|---|
Model | Hi06 | Hi07 | Ci02 | Ri01 | Ri02 | Vi01 | Vi02 |
Spot Image | |||||||
Test Marker | Anti – HIV Anti – HCV Anti - Syphilis |
HBsAg HIV p24 |
CA 19-9 AFP CEA PSA CA 125 |
Flu A Flu B RSV |
Flu A Flu B COVID-19 |
CDV CPV CPIV CAV-2 CCoV |
FCV FPV FVR FIP Chlamydia |
Capacity | 6 ~ 18 T/hr |
Difficulties in operating the system at developing countries |
---|
·Insufficient technical ability |
·Instable electricity supply |
·Small sample scale |
Developed as a solution for given circumstances in developing countries. |
---|
·Smaller equipment |
·Smaller test unit scale |
·Reduced the difficulty of use |